 |
 |

Effect of Medication Nonadherence on Hospitalization and Mortality Among Patients With Diabetes Mellitus
P. Michael Ho, MD, PhD;
John S. Rumsfeld, MD, PhD;
Frederick A. Masoudi, MD, MSPH;
David L. McClure, PhD, MSc;
Mary E. Plomondon, PhD, MSPH;
John F. Steiner, MD, MPH;
David J. Magid, MD, MPH
Arch Intern Med. 2006;166:1836-1841.
Background Medication nonadherence may reduce the effectiveness of therapies. To our knowledge, the association between medication nonadherence and mortality remains unexplored outside the context of clinical trials.
Methods A retrospective cohort study of 11 532 patients with diabetes mellitus in a managed care organization. Medication adherence was calculated as the proportion of days covered for filled prescriptions of oral hypoglycemics, antihypertensives, and statin medications. The primary outcomes of interest were all-cause hospitalization and all-cause mortality. Multivariable regression analyses were performed to assess the independent association between medication adherence and outcomes.
Results Nonadherent patients (proportion of days covered, <80%; prevalence, 21.3%) were younger and had fewer comorbidities compared with adherent patients. During follow-up, nonadherent patients had higher glycosylated hemoglobin, systolic and diastolic blood pressure, and low-density lipoprotein cholesterol levels. In unadjusted analyses, nonadherent patients had higher all-cause hospitalization (23.2% vs 19.2%, P<.001) and higher all-cause mortality (5.9% vs 4.0%, P<.001). In multivariable analyses, medication nonadherence remained significantly associated with increased risks for all-cause hospitalization (odds ratio, 1.58; 95% confidence interval, 1.38-1.81; P<.001) and for all-cause mortality (odds ratio, 1.81; 95% confidence interval, 1.46-2.23; P<.001). The findings were consistent across patient subgroups and using different cutoffs for the proportion of days covered.
Conclusions Medication nonadherence is prevalent among patients with diabetes mellitus and is associated with adverse outcomes. Interventions are needed to increase medication adherence so that patients can realize the full benefit of prescribed therapies.
Author Affiliations: Department of Medicine, Denver Veterans Affairs Medical Center (Drs Ho, Rumsfeld, and Plomondon), Colorado Health Outcomes Program (Drs Masoudi and Steiner), and Departments of Emergency Medicine and of Preventive Medicine and Biometrics (Dr Magid), University of Colorado Health Sciences Center; Clinical Research Unit, Kaiser Permanente of Colorado (Drs McClure and Magid); and Department of Medicine, Denver Health Medical Center (Dr Masoudi); Denver.
RELATED ARTICLES
Improving Medication Adherence: Challenges for Physicians, Payers, and Policy Makers
Patrick J. OConnor
Arch Intern Med. 2006;166(17):1802-1804.
EXTRACT
| FULL TEXT
The Care Transitions Intervention: Results of a Randomized Controlled Trial
Eric A. Coleman, Carla Parry, Sandra Chalmers, and Sung-joon Min
Arch Intern Med. 2006;166(17):1822-1828.
ABSTRACT
| FULL TEXT
Cost-Related Medication Nonadherence Among Elderly and Disabled Medicare Beneficiaries: A National Survey 1 Year Before the Medicare Drug Benefit
Stephen B. Soumerai, Marsha Pierre-Jacques, Fang Zhang, Dennis Ross-Degnan, Alyce S. Adams, Jerry Gurwitz, Gerald Adler, and Dana Gelb Safran
Arch Intern Med. 2006;166(17):1829-1835.
ABSTRACT
| FULL TEXT
Impact of Medication Therapy Discontinuation on Mortality After Myocardial Infarction
P. Michael Ho, John A. Spertus, Frederick A. Masoudi, Kimberly J. Reid, Eric D. Peterson, David J. Magid, Harlan M. Krumholz, and John S. Rumsfeld
Arch Intern Med. 2006;166(17):1842-1847.
ABSTRACT
| FULL TEXT
Improved Therapeutic Monitoring With Several Interventions: A Randomized Trial
Adrianne C. Feldstein, David H. Smith, Nancy Perrin, Xiuhai Yang, Mary Rix, Marsha A. Raebel, David J. Magid, Steven R. Simon, and Stephen B. Soumerai
Arch Intern Med. 2006;166(17):1848-1854.
ABSTRACT
| FULL TEXT
Physician Communication When Prescribing New Medications
Derjung M. Tarn, John Heritage, Debora A. Paterniti, Ron D. Hays, Richard L. Kravitz, and Neil S. Wenger
Arch Intern Med. 2006;166(17):1855-1862.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Clinical Pearls and Strategies to Optimize Patient Outcomes
Joy
The Diabetes Educator 2008;34:54S-59S.
ABSTRACT
| FULL TEXT
Effect of Unrelated Comorbid Conditions on Hypertension Management
Turner et al.
ANN INTERN MED 2008;148:578-586.
ABSTRACT
| FULL TEXT
Is Information the Answer for Hypertension Control?
Peterson
Arch Intern Med 2008;168:259-260.
FULL TEXT
Incidence of Death and Acute Myocardial Infarction Associated With Stopping Clopidogrel After Acute Coronary Syndrome
Ho et al.
JAMA 2008;299:532-539.
ABSTRACT
| FULL TEXT
Race/Ethnicity and Economic Differences in Cost-Related Medication Underuse Among Insured Adults With Diabetes: The Translating Research Into Action for Diabetes Study
Tseng et al.
Diabetes Care 2008;31:261-266.
ABSTRACT
| FULL TEXT
Working With Patients to Enhance Medication Adherence
Lin and Ciechanowski
Clin. Diabetes 2008;26:17-19.
FULL TEXT
Medication Taking and Diabetes: A Systematic Review of the Literature
Odegard and Capoccia
The Diabetes Educator 2007;33:1014-1029.
ABSTRACT
| FULL TEXT
Self-reported Medication Adherence and Cardiovascular Events in Patients With Stable Coronary Heart Disease: The Heart and Soul Study
Gehi et al.
Arch Intern Med 2007;167:1798-1803.
ABSTRACT
| FULL TEXT
Persistent Use of Evidence-Based Pharmacotherapy in Heart Failure Is Associated With Improved Outcomes
Gislason et al.
Circulation 2007;116:737-744.
ABSTRACT
| FULL TEXT
Adherence Is an Agreement, Not a Unilateral Decision
Ullman
DOC News 2007;4:8-9.
FULL TEXT
Relationship Between Adherence to Evidence-Based Pharmacotherapy and Long-term Mortality After Acute Myocardial Infarction
Rasmussen et al.
JAMA 2007;297:177-186.
ABSTRACT
| FULL TEXT
You Aren't Having Any Problems Taking Your Medications, Are You?
Austin
Diabetes Spectr. 2007;20:5-6.
FULL TEXT
A Wake-Up Call About Medication Nonadherence
Journal Watch Cardiology 2006;2006:3-3.
FULL TEXT
|